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ABSTRACT: 
A new replicon suitable for cloning and gene expression was successfully introduced into 
Streptococcus pneumoniae. The non-integrative lactococcal vectors pIL253 (high-copy) and pIL252 
(low-copy), which are based on the promiscuous theta-replicating plasmid pAMβ1, were established 
in pneumococcus. The stability and the small size of these plasmids, together with the presence of 
a helpful multi-cloning site make them a useful genetic tool for gene expression in this bacterium. 
The functionality of the system was tested by cloning and expressing the pneumococcal RNase R 
in pIL253. Full constitutive expression of the cloned gene was observed, clearly demonstrating that 
this plasmid can be used as an expression vector in S. pneumoniae. Moreover, gene expression can 
be regulated by the use of the low- or high-copy vector versions. The existence of other replicative 
plasmids based on this family, which are also probably functional in pneumococcus, further broadens 
the cloning possibilities. We also show that S. pneumoniae cells can accommodate simultaneously 
pIL252 or pIL253 together with the pLS1 plasmid, a pMV158 derivative, which replicates via rolling 
circle mechanism. This fact greatly increases the ability to manipulate this bacterium.
The availability of a novel family of replicative vectors for genetic manipulation in S. pneumoniae 
is an important contribution to the study of this pathogenic microorganism.


















Non-integrative plasmid vectors are very scarce in 
S. pneumoniae and most of the studies have been 
carried out on the broad host range, rolling circle 
replicating (RCR) plasmid pMV158 [1] and on its 
derivative, pLS1 [2]. However, most of the pLS1 
derivatives are large plasmids that are not easy to 
handle. Most of them lack a useful multi-cloning 
site and the respective sequence is often not available. 
These observations prompted us to search for 
cloning vectors based on another replicon that 
could be suitable for the expression of genes in S. 
pneumoniae. pIL253 is a pAMβ1-based plasmid, 
a well characterized theta-replicating promiscuous 
replicon isolated from Enterococcus faecalis [3]. 
Plasmids belonging to the pIL253 family have been 
extensively used for gene cloning and expression 
in Gram-positive bacteria. This is mainly due to 
their small size (< 5 kb) and stability, the presence 
of a useful multi-cloning site (MCS), sequence 
availability and their demonstrated ability to 
stably maintain large DNA inserts in L. lactis [4]. 
Furthermore they are available in low- (pIL252) 
or high- (pIL253) copy number versions [4], which 
allows a better control of gene expression.
We show that the pIL252/pIL253 vector family 
autonomously replicates and is stably maintained 
in S. pneumoniae, and demonstrate the utility of 
this plasmid family as pneumococcal expression 
vectors. Furthermore, these vectors are compatible 
with pLS1, which is undoubtedly one of the most 
useful properties of these plasmids.
2. Results
2.1. pIL253 autonomously replicates in S. 
pneumoniae
pIL253 was isolated from exponentially growing 
S. pneumoniae TIGR4 erythromycin resistant 
transformants (Fig. 1) indicating that this 
plasmid is able to autonomously replicate in 
pneumococcus. The same electrophoretic mobility 
forms as those of the original L. lactis preparation 
were observed. pIL253 therefore seems to be 
structurally stable in S. pneumoniae and it can be 
stably maintained under selective pressure.
Fig. 1: Structural stability of pIL253. 1 -Original pIL253 
preparation; 2- pIL253 extracted from S. pneumoniae; 
3- Original pIL253 prep digested with PstI; 4- S. 
pneumoniae pIL253 prep digested with Pst1.
An analogous result was observed for pIL252, a 
low copy version of pIL253 (data not shown). 
2.2. pIL252/pIL253 compatibility with p LS1
We tested if pIL252/pIL253 could be maintained 
in S. pneumoniae together with pLS1. Plasmids 
extracted from exponentially growing single 
transformants (S. pneumoniae TIGR4 cells carrying 
pLS1, pIL252 or pIL253) were compared with 
those extracted from double transformants (pLS1/
pIL252 or pLS1/pIL252) by restriction analysis. 
The result obtained with pIL252 shows that none of 
the plasmids underwent structural rearrangements 
(Fig. 2). An analogous result was obtained when 
pIL253 was used instead (data not shown). Thus, 
pneumococcal cells are able to stably maintain both 
pIL252/pIL253 vectors and pLS1.
Fig. 2: Compatibility of pIL252 with pLS1. Digestion of 
plasmid preparations with PstI 1- pIL252; 2- pLS1; 3- 
pIL252 + pLS1.
2.3. Gene cloning and expression from pIL253
RNase R expression from pIL253 was evaluated 
by RT-PCR and Western blotting. The results 
in Fig. 3 show that RNase R is highly expressed 
from pIL253. We also observe that expression 
from this plasmid seems to be constitutive and 
does not change with temperature. Full detection 
of RNase R in late exponential cultures indicates 
that the DNA insert remains stable after several 
generations. These results clearly demonstrate that 
the lactococcal vector pIL253 is suitable for gene 
cloning and expression in S. pneumoniae.
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The pIL253 vector, a pAMβ1 derivative, was 
successfully used for cloning and expression 
of a pneumococcal chromosomal gene in host 
cells of  this species. Moreover, this small sized 
vector contains a functional multi-cloning site 
with several unique restriction sites and it is 
able to stably maintain large DNA inserts. The 
possibility of using the low-copy number version 
(pIL252) offers another option for the genetic 
manipulation of  pneumococcus. Moreover, 
the availability of  other plasmid refined tools 
constructed on the basis of  this family with 
different cloning possibilities constitutes an extra 
advantage. Besides pIL253 and pIL252, pIL871, a 
chloramphenicol resistance derivative of pIL253 
was also constructed [5]. pIL253 and pIL871 share 
the same replication protein and can be stably 
maintained in a mixture by double selection with 
erythromycin and chloramphenicol in L. lactis [5]. 
We have also shown that pIL252/pIL253 can be 
maintained in S. pneumonia simultaneously with 
pLS1. This result indicates that these replicons 
are compatible, which significantly broadens their 
potential applications. 
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The introduction of engineering principles to molecular biology promises to represent a critical 
step both towards a deeper understanding of cellular mechanisms as well as to real applications 
by programming synthetic circuits with designed characteristics. With this study, we aim to create 
a genetic platform for synthetic biology in Streptococcus pneumoniae. The model organism is a very 
promising novel chassis for the field since it has a small genome, it becomes naturally competent 
for transformation, there are well established assays and it is an important human pathogen. An 
integration plasmid containing specific restriction sites for BioBrick cloning was created by the Golden 
Gate assembly method. We show that the designed plasmid offers robust and easy cloning and confers 
reliable expression within the pneumococcal genome. Synthetic promoter libraries were created and 
promoters of different strength were identified using bioluminescence assays. In addition, several new 
selection and counter-selection markers and inducible systems for S. pneumoniae were constructed and 
characterized. The methods developed here will help creating similar platforms of the next generation 
and might serve as an excellent starting point for synthetic biology research in bacterial pathogens.
